<DOC>
	<DOCNO>NCT00424580</DOCNO>
	<brief_summary>Montelukast ( asthma ) desloratadine ( allergy ) effective therapy current us . Part happen allergy trigger asthma prevent either drug . This project conduct determine drug effective , either alone combination , control asthma trigger allergy .</brief_summary>
	<brief_title>Airway Responses Montelukast Desloratadine .</brief_title>
	<detailed_description />
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>baseline FEV1 &gt; = 65 % predict positive methacholine challenge ( i.e . methacholine PC20 &lt; = 16mg/ml positive allergen challenge negative skin prick test lung condition/disease asthma currently use montelukast and/or desloratadine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>